QCLS

Business Context and Reporting Period

This Form 8-K filing by Akers Biosciences Inc. (New Jersey) reports on the 2015 Annual Meeting of Stockholders held on August 3, 2015. The report details the voting results for the election of directors and the ratification of the independent registered public accountant.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate governance events rather than a financial statement.

Material Changes

No material financial changes are reported in this filing. The primary event is the successful election of four directors and the ratification of the auditor.

Outlook, Risks, and Management Commentary

Management commentary is limited to the confirmation that a quorum was established, with greater than 40% of outstanding shares present in person or by proxy. No specific guidance, risks, or contingencies are disclosed in this text.

Investor Verification Checklist

• Verify the successful election of Raymond F. Akers, Jr., Ph.D, Thomas Knox, Brandon Knox, and Robert E. Andrews to the Board of Directors.
• Confirm the ratification of MorisonCogen, LP as the independent registered public accountant for the 2015 fiscal year.
• Note that all director nominees received zero votes against/withheld.
• Observe that the auditor ratification proposal received 126,363 votes against/withheld and 2,510 abstentions.

Voting Results Summary